|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T81.30XA |
Disruption of wound, unspecified, initial encounter
|
T8130XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.67%
|
20.08%
|
9.36%
|
5.99%
|
3.25%
|
2.20%
|
1.69%
|
1.11%
|
0.85%
|
0.55%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T81.30XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3,978
|
3,983
|
|
11042
|
DBRDMT SUBQ TIS 1ST 20SQCM/< |
1,590
|
1,590
|
|
87070
|
CULTURE OTHR SPECIMN AEROBIC |
1,576
|
1,661
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,509
|
1,512
|
|
87205
|
SMEAR GRAM STAIN |
1,297
|
1,396
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,149
|
1,173
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,117
|
2,493
|
|
87186
|
MICROBE SUSCEPTIBLE MIC |
1,006
|
1,312
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
988
|
1,363
|
|
99283
|
EMERGENCY DEPT VISIT LOW MDM |
985
|
986
|
|
80053
|
COMPREHEN METABOLIC PANEL |
979
|
980
|
|
80048
|
METABOLIC PANEL TOTAL CA |
729
|
730
|
|
J3010
|
FENTANYL CITRATE INJECTION |
711
|
1,165
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
661
|
2,700
|
|
87075
|
CULTR BACTERIA EXCEPT BLOOD |
641
|
700
|
|
97605
|
NEG PRS WND THER DME<=50SQCM |
618
|
618
|
|
J2405
|
ONDANSETRON HCL INJECTION |
615
|
2,611
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
613
|
16,889
|
|
97597
|
DBRDMT OPN WND 1ST 20 CM/< |
564
|
564
|
|
99284
|
EMERGENCY DEPT VISIT MOD MDM |
548
|
548
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T81.30XA related to the following DRG Codes:
919-921
|
